143 related articles for article (PubMed ID: 21149487)
21. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma.
Brountzos EN; Panagiotou IE; Bafaloukos DI; Kelekis DA
Oncol Rep; 2003; 10(2):505-10. PubMed ID: 12579298
[TBL] [Abstract][Full Text] [Related]
22. [Role of FDG PET-CT in cutaneous melanoma].
Nicol I; Chuto G; Gaudy-Marqueste C; Brenot-Rossi I; Grob JJ; Richard MA
Bull Cancer; 2008 Nov; 95(11):1089-101. PubMed ID: 19036682
[TBL] [Abstract][Full Text] [Related]
23. PET Imaging of Melanoma Using Melanin-Targeted Probe.
Ma X; Cheng Z
Methods Mol Biol; 2021; 2265():407-416. PubMed ID: 33704730
[TBL] [Abstract][Full Text] [Related]
24. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography scanning in malignant melanoma.
Tyler DS; Onaitis M; Kherani A; Hata A; Nicholson E; Keogan M; Fisher S; Coleman E; Seigler HF
Cancer; 2000 Sep; 89(5):1019-25. PubMed ID: 10964332
[TBL] [Abstract][Full Text] [Related]
26. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
27. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
28. Planar coincidence scintigraphy and PET in staging malignant melanoma.
Steinert HC; Voellmy DR; Trachsel C; Bicik I; Buck A; Huch RA; von Schulthess GK
J Nucl Med; 1998 Nov; 39(11):1892-7. PubMed ID: 9829578
[TBL] [Abstract][Full Text] [Related]
29. Baseline staging in cutaneous malignant melanoma.
Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
[TBL] [Abstract][Full Text] [Related]
30. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T
J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608
[TBL] [Abstract][Full Text] [Related]
31. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma.
Saiag P; Bernard M; Beauchet A; Bafounta ML; Bourgault-Villada I; Chagnon S
Arch Dermatol; 2005 Feb; 141(2):183-9. PubMed ID: 15724014
[TBL] [Abstract][Full Text] [Related]
32. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy.
Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J
J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467
[TBL] [Abstract][Full Text] [Related]
33. Melanin-targeted preclinical PET imaging of melanoma metastasis.
Ren G; Miao Z; Liu H; Jiang L; Limpa-Amara N; Mahmood A; Gambhir SS; Cheng Z
J Nucl Med; 2009 Oct; 50(10):1692-9. PubMed ID: 19759116
[TBL] [Abstract][Full Text] [Related]
34. Staging patients with cutaneous malignant melanoma by same-day lymphoscintigraphy and sentinel lymph node biopsy: a single-institutional experience with emphasis on recurrence.
Gad D; Høilund-Carlsen PF; Bartram P; Clemmensen O; Bischoff-Mikkelsen M
J Surg Oncol; 2006 Aug; 94(2):94-100. PubMed ID: 16847917
[TBL] [Abstract][Full Text] [Related]
35. A novel aliphatic 18F-labeled probe for PET imaging of melanoma.
Liu H; Liu S; Miao Z; Jiang H; Deng Z; Hong X; Cheng Z
Mol Pharm; 2013 Sep; 10(9):3384-91. PubMed ID: 23927458
[TBL] [Abstract][Full Text] [Related]
36. PET CT imaging in patients undergoing sentinel node biopsy for melanoma.
Kell MR; Ridge JA; Joseph N; Sigurdson ER
Eur J Surg Oncol; 2007 Sep; 33(7):911-3. PubMed ID: 17207956
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
[TBL] [Abstract][Full Text] [Related]
38. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
Constantinidou A; Hofman M; O'Doherty M; Acland KM; Healy C; Harries M
Melanoma Res; 2008 Feb; 18(1):56-60. PubMed ID: 18227709
[TBL] [Abstract][Full Text] [Related]
39. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution.
Mariani G; Erba P; Manca G; Villa G; Gipponi M; Boni G; Buffoni F; Suriano S; Castagnola F; Bartolomei M; Strauss HW
J Surg Oncol; 2004 Mar; 85(3):141-51. PubMed ID: 14991886
[TBL] [Abstract][Full Text] [Related]
40. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
